SiMSen Diagnostics AB
ABActiveOrg 5592385206MölndalResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2020 · 6 years old4 employees
Loading company…
Riskpilot← Back to searchSign inGet full accessSiMSen Diagnostics AB is a Swedish AB based in Mölndal, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2020, the company has 4 employees and reported revenue of SEK 665.1k in its latest annual filing.
| Revenue | 0.7M SEK | -15% |
| EBITDA | -5.2M SEK | +33% |
| Net profit | -5.4M SEK | +32% |
| Total assets | 3.8M SEK | -4% |
| Equity | 0.9M SEK | +398% |
| Employees | 4 | — |
In its most recent annual report (2025), SiMSen Diagnostics AB reported revenue of SEK 665.1k, a decrease of 15% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 5.4m, and the EBITDA margin stood at -788.1%.
At the end of 2025, equity financed 24% of the balance sheet, and current assets covered short-term debt 0.4 times.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 665 | 778 | 887 | 537 | 0 |
| Staff expenses | -3,958 | -4,785 | — | — | — |
| EBITDA | -5,242 | -7,876 | -3,648 | -1,228 | -418 |
| Depreciation & amort. | -164 | -164 | -111 | -40 | -7 |
| EBIT | -5,406 | -8,041 | -3,759 | -1,268 | -425 |
| Net financials | -6 | 70 | 145 | — | — |
| Profit before tax | -5,412 | -7,970 | -3,614 | -1,268 | -425 |
| Tax | — | -0 | -0 | -0 | -0 |
| Net profit | -5,412 | -7,970 | -3,614 | -1,268 | -425 |
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 3,782 | 3,952 | 9,163 | 1,853 | 2,935 |
| Equity | 908 | -305 | 7,666 | 1,426 | 2,694 |
| Long-term debt | 356 | 356 | 400 | 0 | 0 |
| Short-term debt | 2,518 | 3,901 | 1,097 | 426 | 241 |
| Total debt | 2,874 | 4,256 | 1,497 | 426 | 241 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Net profit as a percentage of total assets — the return generated on the capital employed.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
FP Chief Auditor | Chief Auditor | 2020 |
PC Chief Executive Officer | Chief Executive Officer | 2024 |
BG Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
JE Board of Directors | Board of Directors | 2025 |
AH Deputy Board Member | Deputy Board Member | 2022 |
TE Board of Directors | Board of Directors | 2024 |
EJ Board of Directors | Board of Directors | 2025 |
AB Board of Directors | Board of Directors | 2024 |
DJ Chairman | Chairman | 2025 |
BT Board of Directors | Board of Directors | 2020 – 2020 |
PJ Deputy Board Member | Deputy Board Member | 2020 – 2020 |
HM Board of Directors | Board of Directors | 2020 – 2025 |
MH Chairman | Chairman | 2020 – 2020 |
IH Deputy Board Member | Deputy Board Member | 2022 – 2023 |
AT Board of Directors | Board of Directors | 2022 – 2024 |
MK Board of Directors | Board of Directors | 2022 – 2025 |
SM Deputy Board Member | Deputy Board Member | 2024 – 2025 |
NO Board of Directors | Board of Directors | 2022 – 2023 |
CM Board of Directors | Board of Directors | 2020 – 2025 |
DL Board of Directors | Board of Directors | 2024 – 2025 |
BA Chairman | Chairman | 2022 – 2025 |
JR Chairman | Chairman | 2020 – 2022 |
BT Deputy Board Member | Deputy Board Member | 2020 – 2020 |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Bo Torsten Patrik Nilsson | Deputy Board Member | 25,720 companiesMany roles |
| Bo Torsten Nilsson | Board of Directors | 24,421 companiesMany roles |
| Peter Jonas Michael Carlborg | Deputy Board Member | 9,946 companiesMany roles |
| M H Charlotte Wiberg Larsson | Chairman | 2,992 companiesMany roles |
| Filip Patrik Laurin | Chief Auditor | 209 companiesMany roles |
| Mikael Kubista | Board of Directors | 13 companiesMany roles |
| Jan Erik Gustav Smith | Board of Directors | 12 companiesMany roles |
| Anette Helena Lundquist | Deputy Board Member | 9 companiesMany roles |
| Artur Bernardino Aira | Board of Directors | 7 companiesMany roles |
| Erik Johan Brobjer | Board of Directors | 6 companiesMany roles |
| Nils Olov Nilsson | Board of Directors | 4 companies |
| Bengt Anders Waas | Chairman | 4 companies |
| Daniel Johan Poté | Chairman | 4 companies |
| Anders Torbjörn Ståhlberg | Board of Directors | 3 companies |
| Christina Maria Yvonne Hall | Board of Directors | 3 companies |
| Inger Helena Ströberg | Deputy Board Member | 2 companies |
| Pontus Christian Georg Rehn | Chief Executive Officer | 1 company |
| Sven Mathias Hallin | Deputy Board Member | 1 company |
| Jan Roland Pilebjer | Chairman | 1 company |